ABACAVIR

ABACAVIR was reported 9742 times

ABACAVIR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PHAKOMATOSIS 6 0.8571
1 RETROPERITONEAL DISORDER 10 0.4348
2 IMMUNODEFICIENCY CONGENITAL 10 0.4000
3 PERITONEAL THICKENING 10 0.3571
4 GENETIC POLYMORPHISM 20 0.3509
5 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA 42 0.3256
6 PRIMARY SYPHILIS 5 0.2632
7 PUBERTAL FAILURE 4 0.2353
8 HIV ASSOCIATED NEPHROPATHY 11 0.2157
9 TOTAL LUNG CAPACITY INCREASED 58 0.2132
10 ASTROCYTOMA MALIGNANT 20 0.1942
11 ANTIVIRAL DRUG LEVEL BELOW THERAPEUTIC 7 0.1892
12 AIDS ENCEPHALOPATHY 10 0.1724
13 CSF HIV ESCAPE SYNDROME 22 0.1594
14 TAENIASIS 6 0.1429
15 HIV VIRAEMIA 28 0.1333
16 ERYTHEMA ELEVATUM DIUTINUM 6 0.1304
17 TRIMETHYLAMINURIA 5 0.1220
18 FLOPPY EYELID SYNDROME 4 0.1143
19 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 59 0.1128
20 ISOIMMUNE HAEMOLYTIC DISEASE 4 0.1053
21 ENDOCARDIAL FIBROELASTOSIS 4 0.0930
22 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 10 0.0901
23 VIRAL MUTATION IDENTIFIED 322 0.0873
24 VIROLOGIC FAILURE 423 0.0786
25 MITOCHONDRIAL MYOPATHY 17 0.0780
26 LIPODYSTROPHY ACQUIRED 161 0.0758
27 MITOCHONDRIAL TOXICITY 61 0.0743
28 CONGENITAL INTESTINAL MALFORMATION 8 0.0690
29 AIDS DEMENTIA COMPLEX 4 0.0656
30 CORONARY OSTIAL STENOSIS 8 0.0635
31 AIDS RELATED COMPLICATION 4 0.0615
32 DANDY-WALKER SYNDROME 15 0.0579
33 FOETAL GROWTH ABNORMALITY 9 0.0573
34 ANTIVIRAL DRUG LEVEL ABOVE THERAPEUTIC 4 0.0533
35 TEMPERATURE REGULATION DISORDER 115 0.0516
36 SEGMENTED HYALINISING VASCULITIS 5 0.0490
37 HEPATITIS D 4 0.0476
38 HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION 13 0.0468
39 RENAL ANEURYSM 11 0.0458
40 POST TRANSPLANT DISTAL LIMB SYNDROME 9 0.0443
41 POLYDACTYLY 51 0.0440
42 IIIRD NERVE PARESIS 8 0.0440
43 MACROCEPHALY 16 0.0412
44 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 198 0.0397
45 IMMUNE RECONSTITUTION SYNDROME 51 0.0395
46 ATRIOVENTRICULAR SEPTAL DEFECT 18 0.0383
47 PATHOGEN RESISTANCE 327 0.0358
48 CHOROIDITIS 13 0.0348
49 NEW ONSET DIABETES AFTER TRANSPLANTATION 6 0.0347
50 BLOOD HIV RNA INCREASED 61 0.0336
51 BONE METABOLISM DISORDER 10 0.0332
52 TUBERCULOMA OF CENTRAL NERVOUS SYSTEM 6 0.0330
53 BACTERIAL PYELONEPHRITIS 11 0.0327
54 MUSCULOSKELETAL TOXICITY 6 0.0323
55 ERGOT POISONING 4 0.0320
56 MENINGOMYELOCELE 19 0.0317
57 NEPHROANGIOSCLEROSIS 5 0.0311
58 HYPOMANIA 114 0.0310
59 JAUNDICE CHOLESTATIC 109 0.0308
60 LIPOATROPHY 29 0.0305
61 PORTAL VENOUS GAS 11 0.0303
62 HAEMODIALYSIS COMPLICATION 5 0.0294
63 MESENTERIC ARTERY THROMBOSIS 11 0.0286
64 RENAL TUBULAR DYSFUNCTION 16 0.0283
65 CD4 LYMPHOCYTES INCREASED 6 0.0258
66 FOETAL DEATH 131 0.0252
67 RHODOCOCCUS INFECTION 4 0.0241
68 GASTROSCHISIS 11 0.0231
69 FANCONI SYNDROME ACQUIRED 40 0.0228
70 HISTOLOGY ABNORMAL 5 0.0226
71 OVARIAN FAILURE 12 0.0224
72 FACIAL WASTING 6 0.0223
73 NEURODEVELOPMENTAL DISORDER 15 0.0222
74 KAPOSI'S SARCOMA 11 0.0219
75 FAT REDISTRIBUTION 5 0.0216
76 MENINGITIS TUBERCULOUS 12 0.0215
77 AMOEBIASIS 5 0.0213
78 ACQUIRED IMMUNODEFICIENCY SYNDROME 11 0.0212
79 GRAFT DYSFUNCTION 6 0.0211
80 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 7 0.0209
81 GRAFT INFECTION 7 0.0206
82 MITOCHONDRIAL CYTOPATHY 9 0.0205
83 INFECTIVE ANEURYSM 10 0.0202
84 DELAYED PUBERTY 5 0.0197
85 MYCOBACTERIUM TEST POSITIVE 4 0.0194
86 MULTIPLE-DRUG RESISTANCE 60 0.0193
87 CD4 LYMPHOCYTES DECREASED 40 0.0187
88 TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM 5 0.0185
89 TRISOMY 21 23 0.0183
90 SECONDARY HYPOGONADISM 6 0.0182
91 NEURAL TUBE DEFECT 13 0.0179
92 HIV INFECTION 53 0.0176
93 RETINAL TOXICITY 18 0.0175
94 ENTEROVIRUS INFECTION 14 0.0162
95 GENE MUTATION 32 0.0162
96 FOOD ALLERGY 124 0.0160
97 DYSLIPIDAEMIA 80 0.0157
98 CEREBRAL TOXOPLASMOSIS 14 0.0150
99 MENINGITIS CRYPTOCOCCAL 25 0.0143
100 LIFE EXPECTANCY SHORTENED 8 0.0141
101 DELAYED GRAFT FUNCTION 10 0.0141
102 BIOPSY KIDNEY 4 0.0140
103 NODULAR REGENERATIVE HYPERPLASIA 9 0.0140
104 SUPERINFECTION BACTERIAL 11 0.0139
105 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 15 0.0139
106 SCHIZOPHRENIA 166 0.0136
107 ABDOMINAL SEPSIS 12 0.0136
108 CONGENITAL MUSCULOSKELETAL ANOMALY 6 0.0136
109 RHINITIS ALLERGIC 59 0.0132
110 CONGENITAL FOOT MALFORMATION 6 0.0132
111 EXTRAOCULAR MUSCLE PARESIS 6 0.0131
112 CUSHING'S SYNDROME 9 0.0129
113 OPHTHALMOPLEGIA 20 0.0127
114 ANAEMIA NEONATAL 6 0.0124
115 DISEASE RISK FACTOR 5 0.0124
116 PSEUDOCYST 4 0.0124
117 EXTRAOCULAR MUSCLE DISORDER 4 0.0124
118 PANCREATITIS RELAPSING 10 0.0122
119 SARCOIDOSIS 58 0.0122
120 FANCONI SYNDROME 17 0.0120
121 GRAFT COMPLICATION 7 0.0119
122 NASAL POLYPS 58 0.0118
123 GENOTYPE DRUG RESISTANCE TEST POSITIVE 12 0.0117
124 HEART TRANSPLANT REJECTION 12 0.0116
125 TOXIC OPTIC NEUROPATHY 5 0.0115
126 CHRONIC ALLOGRAFT NEPHROPATHY 9 0.0115
127 DRUG RESISTANCE 292 0.0114
128 COELIAC DISEASE 110 0.0112
129 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 4 0.0111
130 HYDROURETER 4 0.0105
131 OPHTHALMIC HERPES SIMPLEX 6 0.0104
132 GLYCOSURIA 14 0.0104
133 RENAL TUBULAR ACIDOSIS 22 0.0101
134 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 11 0.0100
135 CONGENITAL HYDROCEPHALUS 5 0.0099
136 IMMUNODEFICIENCY 146 0.0098
137 VIRAL LOAD INCREASED 38 0.0098
138 RENAL INFARCT 14 0.0097
139 LIPOHYPERTROPHY 6 0.0096
140 SYPHILIS 7 0.0096
141 CRYPTOSPORIDIOSIS INFECTION 5 0.0095
142 WHITE MATTER LESION 12 0.0095
143 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 8 0.0095
144 PORTAL HYPERTENSION 29 0.0094
145 THYROXINE FREE INCREASED 6 0.0094
146 BRONCHIECTASIS 63 0.0093
147 HYPERLACTACIDAEMIA 25 0.0093
148 MYCOBACTERIUM AVIUM COMPLEX INFECTION 25 0.0093
149 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 30 0.0091
150 BURSITIS 110 0.0091
151 BONE DEFORMITY 6 0.0089
152 INTRACRANIAL HAEMATOMA 5 0.0089
153 CYTOMEGALOVIRUS CHORIORETINITIS 17 0.0087
154 CHOLESTASIS OF PREGNANCY 4 0.0087
155 VIRAEMIA 12 0.0087
156 MENINGISM 4 0.0085
157 CARDIAC VENTRICULAR THROMBOSIS 11 0.0085
158 CSF PROTEIN INCREASED 7 0.0084
159 COCCIDIOIDOMYCOSIS 10 0.0084
160 GINGIVAL HYPERPLASIA 5 0.0083
161 CACHEXIA 42 0.0082
162 LYMPH NODE TUBERCULOSIS 6 0.0081
163 PLAGIOCEPHALY 4 0.0080
164 HISTOPLASMOSIS 14 0.0079
165 ANOGENITAL WARTS 7 0.0078
166 SPINA BIFIDA 16 0.0077
167 PNEUMONIA INFLUENZAL 9 0.0076
168 CARDIAC MURMUR 65 0.0075
169 TOXOPLASMOSIS 8 0.0074
170 HEPATOSPLENOMEGALY 19 0.0074
171 EYELID PTOSIS 75 0.0074
172 CRYSTALLURIA 4 0.0074
173 INFERTILITY 11 0.0073
174 METABOLIC SYNDROME 12 0.0073
175 OESOPHAGEAL CANDIDIASIS 29 0.0073
176 BLOOD INSULIN INCREASED 4 0.0072
177 GINGIVAL HYPERTROPHY 11 0.0072
178 CLEFT LIP AND PALATE 8 0.0072
179 OSTEOMALACIA 11 0.0071
180 PYLORIC STENOSIS 6 0.0071
181 MEGACOLON 11 0.0070
182 MOTOR DEVELOPMENTAL DELAY 4 0.0069
183 STILLBIRTH 33 0.0068
184 POSTPARTUM HAEMORRHAGE 9 0.0067
185 ANAEMIA OF CHRONIC DISEASE 6 0.0066
186 BONE DEMINERALISATION 7 0.0066
187 PRESCRIBED OVERDOSE 128 0.0066
188 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 7 0.0066
189 CYTOMEGALOVIRUS COLITIS 15 0.0065
190 CALCULUS URINARY 10 0.0065
191 PORTAL VEIN THROMBOSIS 21 0.0065
192 HYPERTRICHOSIS 12 0.0065
193 OESOPHAGEAL VARICES HAEMORRHAGE 14 0.0064
194 MYELOPATHY 12 0.0063
195 ARNOLD-CHIARI MALFORMATION 6 0.0063
196 HEPATOTOXICITY 140 0.0063
197 BLOOD CORTISOL DECREASED 4 0.0063
198 PARAPARESIS 11 0.0062
199 RENAL TUBULAR DISORDER 17 0.0060
200 GLOMERULONEPHRITIS MEMBRANOUS 7 0.0060
201 AMAUROSIS 5 0.0059
202 HYPERTRIGLYCERIDAEMIA 34 0.0058
203 ATTENTION DEFICIT HYPERACTIVITY DISORDER 24 0.0057
204 MALARIA 4 0.0057
205 RENAL TUBULAR ATROPHY 5 0.0057
206 FOETAL HEART RATE DECELERATION ABNORMALITY 4 0.0057
207 ASTERIXIS 6 0.0056
208 SPEECH DISORDER DEVELOPMENTAL 16 0.0056
209 BLOOD MAGNESIUM INCREASED 5 0.0055
210 NEUROPSYCHIATRIC SYMPTOMS 5 0.0055
211 BLOOD BILIRUBIN UNCONJUGATED INCREASED 4 0.0055
212 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 45 0.0055
213 NEPHROPATHY TOXIC 61 0.0054
214 PRURIGO 5 0.0054
215 BLOOD BILIRUBIN INCREASED 145 0.0054
216 NON-HODGKIN'S LYMPHOMA 7 0.0053
217 CHOLELITHIASIS 175 0.0053
218 GENITAL HERPES 8 0.0052
219 HYPERPARATHYROIDISM SECONDARY 13 0.0052
220 EXPOSURE DURING PREGNANCY 315 0.0051
221 ENTEROCOCCAL INFECTION 24 0.0050
222 HEPATIC FIBROSIS 17 0.0049
223 LIVE BIRTH 41 0.0049
224 TRANSPLANT REJECTION 39 0.0049
225 OPPORTUNISTIC INFECTION 9 0.0049
226 DISSEMINATED TUBERCULOSIS 12 0.0047
227 MALIGNANT HYPERTENSION 4 0.0047
228 SECONDARY ADRENOCORTICAL INSUFFICIENCY 7 0.0046
229 PSYCHIATRIC DECOMPENSATION 9 0.0046
230 FOETAL GROWTH RESTRICTION 28 0.0046
231 SPINAL CORD INJURY 8 0.0046
232 AXONAL NEUROPATHY 4 0.0046
233 BLOOD LACTIC ACID INCREASED 24 0.0046
234 UPPER RESPIRATORY TRACT INFECTION 208 0.0045
235 TRANSPLANT FAILURE 11 0.0045
236 BLOOD ALKALINE PHOSPHATASE ABNORMAL 4 0.0044
237 OROPHARYNGEAL CANDIDIASIS 4 0.0044
238 STRABISMUS 13 0.0044
239 HISTOPLASMOSIS DISSEMINATED 7 0.0044
240 COMPLICATIONS OF TRANSPLANTED KIDNEY 10 0.0044
241 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 7 0.0044
242 TREATMENT FAILURE 361 0.0044
243 PSYCHOTIC DISORDER 128 0.0043
244 INSULIN RESISTANCE 9 0.0043
245 OSTEOCHONDROSIS 5 0.0043
246 ANHEDONIA 113 0.0043
247 RASH ERYTHEMATOUS 204 0.0043
248 HYDROCEPHALUS 23 0.0042
249 PRE-ECLAMPSIA 20 0.0042
250 FOETAL EXPOSURE DURING PREGNANCY 340 0.0042
251 END STAGE RENAL DISEASE 76 0.0042
252 HERPES VIRUS INFECTION 24 0.0042
253 LUNG CANCER METASTATIC 12 0.0042
254 BK VIRUS INFECTION 14 0.0041
255 ENCEPHALITIS VIRAL 5 0.0041
256 PNEUMOCYSTIS JIROVECI PNEUMONIA 9 0.0040
257 HEMIANOPIA 4 0.0040
258 KIDNEY FIBROSIS 7 0.0040
259 HEPATITIS CHOLESTATIC 24 0.0040
260 PULMONARY TUBERCULOSIS 17 0.0040
261 VARICES OESOPHAGEAL 12 0.0040
262 TREATMENT NONCOMPLIANCE 217 0.0040
263 PANCREATIC FAILURE 7 0.0040
264 HYPOGONADISM 4 0.0040
265 HEPATIC ENZYME INCREASED 268 0.0039
266 INDURATION 7 0.0039
267 DUODENITIS 12 0.0039
268 RENAL TUBULAR NECROSIS 38 0.0039
269 INTERMITTENT CLAUDICATION 6 0.0038
270 CONTRAINDICATED PRODUCT ADMINISTERED 113 0.0037
271 LYMPHADENITIS 9 0.0037
272 OCULAR ICTERUS 16 0.0037
273 HEPATITIS C 44 0.0036
274 ECONOMIC PROBLEM 55 0.0036
275 ENCEPHALITIS 25 0.0036
276 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 4 0.0036
277 ATROPHY 7 0.0036
278 PYELONEPHRITIS ACUTE 7 0.0036
279 ATYPICAL MYCOBACTERIAL INFECTION 5 0.0035
280 BLOOD AMYLASE INCREASED 6 0.0035
281 DECREASED IMMUNE RESPONSIVENESS 34 0.0035
282 SMALL FOR DATES BABY 17 0.0034
283 HYPERBILIRUBINAEMIA 35 0.0034
284 NEPHROCALCINOSIS 4 0.0034
285 MYOPATHY 29 0.0034
286 ORAL CANDIDIASIS 44 0.0033
287 RENAL TUBULAR INJURY 4 0.0033
288 HYPOPHOSPHATAEMIA 24 0.0032
289 PROTEINURIA 61 0.0032
290 ACUTE HEPATIC FAILURE 43 0.0031
291 RENAL COLIC 7 0.0031
292 LIVER TRANSPLANT 11 0.0030
293 NEPHROGENIC ANAEMIA 14 0.0030
294 HYPERLIPIDAEMIA 36 0.0030
295 BRAIN OEDEMA 38 0.0030
296 AREFLEXIA 8 0.0030
297 HEPATOMEGALY 29 0.0029
298 MUCOUS MEMBRANE DISORDER 4 0.0029
299 TALIPES 9 0.0029
300 PROCEDURAL HAEMORRHAGE 11 0.0028
301 NEPHROPATHY 26 0.0028
302 LIVER TRANSPLANT REJECTION 5 0.0028
303 LABELLED DRUG-DRUG INTERACTION ISSUE 4 0.0028
304 FAT TISSUE INCREASED 4 0.0028
305 DIABETES MELLITUS NON-INSULIN-DEPENDENT 4 0.0027
306 ASPERGILLUS INFECTION 18 0.0027
307 PARADOXICAL DRUG REACTION 10 0.0027
308 APRAXIA 4 0.0027
309 LYMPH NODE PAIN 5 0.0027
310 LEUKOENCEPHALOPATHY 10 0.0027
311 ADRENAL INSUFFICIENCY 32 0.0026
312 BRONCHOPNEUMONIA 9 0.0026
313 NEUROLOGICAL SYMPTOM 15 0.0026
314 LYMPHADENOPATHY MEDIASTINAL 5 0.0026
315 HYPOREFLEXIA 5 0.0026
316 PREMATURE SEPARATION OF PLACENTA 4 0.0026
317 CORONARY ARTERY STENOSIS 13 0.0026
318 DRUG INTERACTION 409 0.0026
319 CAROTID ARTERY STENOSIS 9 0.0026
320 RESPIRATORY TRACT INFECTION VIRAL 6 0.0026
321 OSTEOPENIA 39 0.0026
322 SPLENOMEGALY 30 0.0026
323 BLOOD IMMUNOGLOBULIN E INCREASED 6 0.0025
324 HYPOGLYCAEMIA NEONATAL 4 0.0025
325 CRYPTOCOCCOSIS 4 0.0025
326 THROMBOCYTOPENIA 272 0.0024
327 PSYCHOTIC SYMPTOM 5 0.0024
328 DRUG LEVEL INCREASED 40 0.0024
329 EXPOSURE DURING BREAST FEEDING 8 0.0024
330 CENTRAL NERVOUS SYSTEM LESION 33 0.0024
331 ENTEROBACTER INFECTION 4 0.0024
332 ALANINE AMINOTRANSFERASE ABNORMAL 5 0.0024
333 EROSIVE OESOPHAGITIS 4 0.0024
334 HEPATIC ENCEPHALOPATHY 22 0.0024
335 ANAEMIA MACROCYTIC 5 0.0023
336 LUNG NEOPLASM 10 0.0023
337 RENAL IMPAIRMENT 196 0.0023
338 EXOPHTHALMOS 5 0.0023
339 BLOOD CHLORIDE INCREASED 4 0.0023
340 FLUID RETENTION 117 0.0023
341 POLYDIPSIA 9 0.0023
342 ILEUS PARALYTIC 10 0.0022
343 LEFT VENTRICULAR DYSFUNCTION 15 0.0022
344 BLOOD CREATININE DECREASED 7 0.0022
345 PERIPHERAL VENOUS DISEASE 9 0.0022
346 GLUCOSE TOLERANCE IMPAIRED 13 0.0022
347 DRUG LEVEL BELOW THERAPEUTIC 12 0.0022
348 LYMPHOEDEMA 15 0.0022
349 BACTERIAL SEPSIS 7 0.0021
350 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 5 0.0021
351 FAILURE TO THRIVE 11 0.0021
352 DIPLOPIA 55 0.0021
353 GLOMERULAR FILTRATION RATE DECREASED 26 0.0021
354 BLOOD BICARBONATE DECREASED 4 0.0021
355 NEUROTOXICITY 37 0.0021
356 AUTOIMMUNE HAEMOLYTIC ANAEMIA 7 0.0020
357 LACTIC ACIDOSIS 66 0.0020
358 PREMATURE BABY 61 0.0020
359 HEPATIC CIRRHOSIS 38 0.0020
360 HEPATITIS FULMINANT 6 0.0020
361 HISTIOCYTOSIS HAEMATOPHAGIC 6 0.0020
362 LOW BIRTH WEIGHT BABY 16 0.0020
363 JAUNDICE 54 0.0020
364 INTESTINAL ISCHAEMIA 11 0.0020
365 HEPATITIS B 12 0.0020
366 INTRACRANIAL PRESSURE INCREASED 11 0.0020
367 MACULOPATHY 7 0.0020
368 PREMATURE LABOUR 11 0.0019
369 HAEMOLYSIS 15 0.0019
370 RENAL TRANSPLANT 7 0.0019
371 ACUTE MYOCARDIAL INFARCTION 57 0.0019
372 INFUSION RELATED REACTION 128 0.0019
373 HEPATITIS TOXIC 5 0.0019
374 BLOOD PHOSPHORUS DECREASED 7 0.0019
375 LIVEDO RETICULARIS 4 0.0019
376 COLITIS MICROSCOPIC 9 0.0019
377 IRIDOCYCLITIS 6 0.0019
378 FOETAL DISTRESS SYNDROME 4 0.0019
379 CUSHINGOID 6 0.0019
380 PSEUDOMONAS INFECTION 16 0.0019
381 CYTOMEGALOVIRUS INFECTION 31 0.0019
382 HEPATIC NECROSIS 7 0.0019
383 CHRONIC KIDNEY DISEASE 141 0.0019
384 LYMPHADENOPATHY 65 0.0018
385 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 7 0.0018
386 TUBULOINTERSTITIAL NEPHRITIS 34 0.0018
387 ARTERIOSCLEROSIS 17 0.0018
388 RHINOVIRUS INFECTION 7 0.0018
389 CARDIOPULMONARY FAILURE 7 0.0018
390 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 46 0.0018
391 ASTHMA 202 0.0018
392 TORSADE DE POINTES 14 0.0018
393 RHEUMATOID ARTHRITIS 201 0.0018
394 ATAXIA 21 0.0018
395 BLOOD THYROID STIMULATING HORMONE DECREASED 8 0.0018
396 HYPERPHAGIA 7 0.0018
397 APLASIA PURE RED CELL 6 0.0017
398 VIITH NERVE PARALYSIS 6 0.0017
399 HYDRONEPHROSIS 13 0.0017
400 GRANULOMA 6 0.0017
401 APHTHOUS STOMATITIS 4 0.0017
402 OSTEOPOROSIS 71 0.0017
403 ESCHERICHIA SEPSIS 5 0.0017
404 GAMMA-GLUTAMYLTRANSFERASE INCREASED 38 0.0017
405 TRANSAMINASES INCREASED 38 0.0017
406 HERPES SIMPLEX 11 0.0017
407 DRUG TOXICITY 23 0.0017
408 LUNG NEOPLASM MALIGNANT 69 0.0017
409 DRUG LEVEL DECREASED 17 0.0017
410 PREMATURE RUPTURE OF MEMBRANES 4 0.0017
411 HYPERCHOLESTEROLAEMIA 16 0.0017
412 GUILLAIN-BARRE SYNDROME 8 0.0017
413 EMBOLISM VENOUS 5 0.0016
414 ATRIOVENTRICULAR BLOCK SECOND DEGREE 5 0.0016
415 MAJOR DEPRESSION 12 0.0016
416 GLOMERULONEPHRITIS 4 0.0016
417 CAESAREAN SECTION 19 0.0016
418 METABOLIC ACIDOSIS 52 0.0016
419 AMYLASE INCREASED 6 0.0016
420 STAPHYLOCOCCAL SEPSIS 8 0.0016
421 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 4 0.0016
422 MATERNAL EXPOSURE DURING PREGNANCY 142 0.0016
423 CYTOMEGALOVIRUS INFECTION REACTIVATION 7 0.0016
424 NON-CARDIAC CHEST PAIN 5 0.0016
425 TOXIC ENCEPHALOPATHY 8 0.0016
426 BLOOD URIC ACID INCREASED 9 0.0016
427 CORONARY ARTERY DISEASE 47 0.0016
428 PAPILLOEDEMA 7 0.0015
429 CONGENITAL ANOMALY 12 0.0015
430 VITAMIN D DEFICIENCY 15 0.0015
431 LYMPHOCYTE COUNT INCREASED 5 0.0015
432 SKIN ODOUR ABNORMAL 6 0.0015
433 CYTOLYTIC HEPATITIS 5 0.0015
434 HIGH DENSITY LIPOPROTEIN DECREASED 5 0.0015
435 DRUG-INDUCED LIVER INJURY 47 0.0015
436 PNEUMOCYSTIS JIROVECII PNEUMONIA 15 0.0015
437 ABORTION INDUCED 14 0.0015
438 CARDIAC TAMPONADE 7 0.0015
439 NORMAL NEWBORN 8 0.0015
440 BLOOD CREATININE INCREASED 96 0.0015
441 POLYURIA 12 0.0015
442 INTENTIONAL PRODUCT MISUSE 128 0.0015
443 CLONUS 4 0.0015
444 DRUG INTOLERANCE 141 0.0015
445 NEPHROTIC SYNDROME 10 0.0015
446 PHARYNGITIS 18 0.0014
447 HEPATIC STEATOSIS 27 0.0014
448 MATERNAL DRUGS AFFECTING FOETUS 11 0.0014
449 MUSCLE ATROPHY 18 0.0014
450 HYPERVOLAEMIA 7 0.0014
451 RENAL FAILURE 187 0.0014
452 PATHOLOGICAL FRACTURE 7 0.0014
453 PYREXIA 474 0.0014
454 BLOOD ALKALINE PHOSPHATASE INCREASED 34 0.0014
455 BLOOD TRIGLYCERIDES INCREASED 24 0.0014
456 CEREBRAL DISORDER 10 0.0014
457 ACUTE KIDNEY INJURY 205 0.0013
458 HEMIPLEGIA 11 0.0013
459 CLOSTRIDIUM DIFFICILE COLITIS 14 0.0013
460 RECTAL CANCER 4 0.0013
461 RENAL FAILURE ACUTE 55 0.0013
462 CHOLANGITIS 8 0.0013
463 DISSEMINATED INTRAVASCULAR COAGULATION 18 0.0013
464 FOREIGN BODY IN THROAT 4 0.0013
465 QUALITY OF LIFE DECREASED 17 0.0013
466 HEPATITIS B REACTIVATION 4 0.0013
467 LEUKOPENIA 63 0.0013
468 POLYNEUROPATHY 15 0.0013
469 TACHYPNOEA 17 0.0012
470 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 65 0.0012
471 INFECTION 180 0.0012
472 ANAEMIA 233 0.0012
473 OSTEONECROSIS 40 0.0012
474 HYPERURICAEMIA 5 0.0012
475 HEPATITIS 31 0.0012
476 PROTEIN URINE PRESENT 6 0.0012
477 SKIN LESION 33 0.0012
478 NERVOUS SYSTEM DISORDER 37 0.0012
479 HYPERTHYROIDISM 17 0.0012
480 GASTROENTERITIS 17 0.0012
481 HAEMATOTOXICITY 11 0.0012
482 PYELONEPHRITIS 10 0.0012
483 BONE DENSITY DECREASED 36 0.0011
484 ASPARTATE AMINOTRANSFERASE INCREASED 61 0.0011
485 ABORTION SPONTANEOUS 46 0.0011
486 CHOLESTASIS 22 0.0011
487 CATATONIA 6 0.0011
488 ONYCHOMYCOSIS 5 0.0011
489 NECROTISING FASCIITIS 4 0.0011
490 HYPERTENSION 240 0.0011
491 HYPERSENSITIVITY 210 0.0011
492 HEPATIC FAILURE 34 0.0011
493 OLIGURIA 7 0.0011
494 RETCHING 24 0.0011
495 HYPERHIDROSIS 145 0.0011
496 ALANINE AMINOTRANSFERASE INCREASED 69 0.0011
497 CARDIOTOXICITY 10 0.0011
498 TOXIC EPIDERMAL NECROLYSIS 17 0.0011
499 EYELID OEDEMA 13 0.0011
500 MYOSITIS 10 0.0011
501 PREGNANCY 22 0.0011
502 PANCYTOPENIA 61 0.0011
503 PNEUMONIA BACTERIAL 10 0.0011
504 GASTROOESOPHAGEAL REFLUX DISEASE 87 0.0011
505 JOINT SWELLING 130 0.0011
506 DRUG EXPOSURE DURING PREGNANCY 36 0.0011
507 EMOTIONAL DISTRESS 128 0.0011
508 KIDNEY TRANSPLANT REJECTION 5 0.0010
509 MULTI-ORGAN FAILURE 18 0.0010
510 FAECAL INCONTINENCE 5 0.0010
511 RENAL FAILURE CHRONIC 8 0.0010
512 WHEEZING 61 0.0010
513 AMENORRHOEA 18 0.0010
514 IMMUNOSUPPRESSION 9 0.0010
515 PULMONARY HYPERTENSION 21 0.0010
516 HYPERTRANSAMINASAEMIA 7 0.0010
517 ODYNOPHAGIA 6 0.0010
518 CEREBRAL ATROPHY 4 0.0010
519 ANAL INCONTINENCE 9 0.0010
520 BRAIN INJURY 10 0.0010
521 LIVER FUNCTION TEST ABNORMAL 29 0.0010
522 FEMORAL NECK FRACTURE 5 0.0010
523 LYMPHOMA 15 0.0010
524 AGRANULOCYTOSIS 18 0.0010
525 TONSILLITIS 5 0.0010
526 FOOT FRACTURE 18 0.0009
527 RENAL DISORDER 44 0.0009
528 RASH MACULO-PAPULAR 21 0.0009
529 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 9 0.0009
530 PREMATURE DELIVERY 15 0.0009
531 NEPHROLITHIASIS 43 0.0009
532 LEFT VENTRICULAR HYPERTROPHY 4 0.0009
533 SKIN HYPERPIGMENTATION 8 0.0009
534 PANCREATITIS 49 0.0009
535 MYOCLONUS 11 0.0009
536 PSORIASIS 120 0.0009
537 MELANOCYTIC NAEVUS 4 0.0009
538 DYSPHEMIA 4 0.0009
539 IMMUNE SYSTEM DISORDER 12 0.0009
540 LOW DENSITY LIPOPROTEIN INCREASED 7 0.0009
541 HYPOALBUMINAEMIA 7 0.0009
542 STEVENS-JOHNSON SYNDROME 20 0.0009
543 NECROSIS 5 0.0009
544 ATRIOVENTRICULAR BLOCK COMPLETE 6 0.0009
545 MALNUTRITION 10 0.0009
546 HEMIPARESIS 15 0.0009
547 BLOOD TESTOSTERONE DECREASED 6 0.0009
548 TOXICITY TO VARIOUS AGENTS 147 0.0009
549 ISCHAEMIA 4 0.0009
550 HYPOKALAEMIA 40 0.0009
551 SOCIAL AVOIDANT BEHAVIOUR 5 0.0009
552 DIARRHOEA HAEMORRHAGIC 8 0.0009
553 MULTIPLE FRACTURES 14 0.0009
554 ESCHERICHIA INFECTION 7 0.0009
555 ASCITES 25 0.0008
556 SPINAL COMPRESSION FRACTURE 7 0.0008
557 DIALYSIS 12 0.0008
558 BACTERAEMIA 10 0.0008
559 COAGULOPATHY 14 0.0008
560 EOSINOPHIL COUNT INCREASED 7 0.0008
561 HYPOVOLAEMIC SHOCK 4 0.0008
562 DECREASED ACTIVITY 9 0.0008
563 RASH VESICULAR 4 0.0008
564 DISEASE RECURRENCE 39 0.0008
565 PRODUCT USE ISSUE 153 0.0008
566 ANURIA 7 0.0008
567 MULTIPLE ORGAN DYSFUNCTION SYNDROME 23 0.0008
568 PANCREATIC DISORDER 4 0.0008
569 PIGMENTATION DISORDER 5 0.0008
570 RASH 352 0.0008
571 RESPIRATORY FAILURE 58 0.0008
572 VOMITING 373 0.0008
573 LUNG INFILTRATION 7 0.0008
574 MYOCARDIAL ISCHAEMIA 9 0.0008
575 HAEMODYNAMIC INSTABILITY 6 0.0008
576 MYOCARDITIS 9 0.0008
577 LIPASE INCREASED 6 0.0008
578 CEREBRAL ISCHAEMIA 4 0.0008
579 METASTASES TO CENTRAL NERVOUS SYSTEM 10 0.0008
580 ELECTROLYTE IMBALANCE 9 0.0008
581 ENCEPHALOPATHY 19 0.0008
582 HEPATITIS ACUTE 5 0.0008
583 MALABSORPTION 4 0.0008
584 REFUSAL OF TREATMENT BY PATIENT 5 0.0008
585 BLOOD CREATINE PHOSPHOKINASE INCREASED 22 0.0008
586 HYPONATRAEMIA 43 0.0008
587 INCONTINENCE 8 0.0008
588 RENAL CYST 6 0.0008
589 WRIST FRACTURE 9 0.0008
590 SKIN MASS 5 0.0007
591 MENINGITIS 5 0.0007
592 SENSORY LOSS 6 0.0007
593 RHABDOMYOLYSIS 31 0.0007
594 BLOOD SODIUM DECREASED 14 0.0007
595 EOSINOPHILIA 13 0.0007
596 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 5 0.0007
597 INFARCTION 5 0.0007
598 PNEUMONIA 236 0.0007
599 DEAFNESS 19 0.0007
600 PERITONITIS 15 0.0007
601 THROMBOTIC MICROANGIOPATHY 7 0.0007
602 ATRIAL SEPTAL DEFECT 6 0.0007
603 DEVICE RELATED INFECTION 11 0.0007
604 OEDEMA PERIPHERAL 87 0.0007
605 HYPERGLYCAEMIA 26 0.0007
606 PAPULE 5 0.0007
607 STATUS EPILEPTICUS 8 0.0007
608 FACIAL PARALYSIS 6 0.0007
609 RETINAL HAEMORRHAGE 5 0.0007
610 HYPOTONIA 7 0.0007
611 NEUTROPENIC SEPSIS 5 0.0007
612 ANOREXIA 9 0.0007
613 BLOOD MAGNESIUM DECREASED 6 0.0007
614 BLOOD LACTATE DEHYDROGENASE INCREASED 11 0.0007
615 PNEUMONIA ASPIRATION 17 0.0007
616 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 6 0.0007
617 CONDITION AGGRAVATED 205 0.0007
618 FEELING DRUNK 5 0.0007
619 PROTHROMBIN TIME PROLONGED 4 0.0007
620 PANCREATITIS ACUTE 15 0.0007
621 JOINT DISLOCATION 7 0.0007
622 RENAL PAIN 7 0.0007
623 CORONARY ARTERY OCCLUSION 9 0.0007
624 LIVER DISORDER 29 0.0007
625 ABNORMAL DREAMS 18 0.0007
626 NEUROPATHY PERIPHERAL 62 0.0007
627 MUCOSAL INFLAMMATION 17 0.0006
628 NEUTROPENIA 88 0.0006
629 BRONCHOPULMONARY ASPERGILLOSIS 5 0.0006
630 HEPATIC FUNCTION ABNORMAL 24 0.0006
631 OESOPHAGITIS 7 0.0006
632 RENAL INJURY 19 0.0006
633 ELECTROCARDIOGRAM QT PROLONGED 23 0.0006
634 LYMPHOPENIA 9 0.0006
635 BACK PAIN 147 0.0006
636 APHASIA 19 0.0006
637 OVERDOSE 135 0.0006
638 AFFECT LABILITY 6 0.0006
639 THERAPY NON-RESPONDER 28 0.0006
640 RASH GENERALISED 16 0.0006
641 PARKINSONISM 6 0.0006
642 HAEMATURIA 21 0.0006
643 NODULE 8 0.0006
644 SHOCK 14 0.0006
645 GASTRITIS 16 0.0006
646 URINARY INCONTINENCE 18 0.0006
647 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
648 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 29 0.0006
649 APPETITE DISORDER 4 0.0006
650 ERYTHEMA 122 0.0006
651 COLITIS ISCHAEMIC 4 0.0006
652 CANDIDA INFECTION 10 0.0006
653 HAEMATEMESIS 15 0.0006
654 CONSTIPATION 129 0.0006
655 PALLOR 16 0.0006
656 ERECTILE DYSFUNCTION 15 0.0006
657 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 10 0.0006
658 SEPSIS 65 0.0006
659 LUNG INFECTION 9 0.0006
660 COGNITIVE DISORDER 27 0.0006
661 DIABETES MELLITUS 44 0.0006
662 LABORATORY TEST ABNORMAL 17 0.0006
663 ACUTE RESPIRATORY FAILURE 11 0.0006
664 PNEUMOTHORAX 9 0.0006
665 MYOCARDIAL INFARCTION 99 0.0006
666 SUDDEN DEATH 6 0.0006
667 GENERALISED OEDEMA 7 0.0006
668 PRURITUS GENERALISED 12 0.0006
669 SEPTIC SHOCK 24 0.0006
670 HEPATIC CYTOLYSIS 7 0.0005
671 DYSPHAGIA 52 0.0005
672 VENTRICULAR TACHYCARDIA 9 0.0005
673 GENERALISED TONIC-CLONIC SEIZURE 9 0.0005
674 BACTERIAL INFECTION 10 0.0005
675 RASH PAPULAR 12 0.0005
676 OEDEMA 29 0.0005
677 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0005
678 SCAB 6 0.0005
679 HEPATOCELLULAR CARCINOMA 4 0.0005
680 DERMATITIS 11 0.0005
681 ACIDOSIS 4 0.0005
682 NIGHTMARE 18 0.0005
683 PRODUCT TASTE ABNORMAL 7 0.0005
684 ANKLE FRACTURE 8 0.0005
685 HAEMOGLOBIN DECREASED 53 0.0005
686 VASCULITIS 6 0.0005
687 IMPAIRED WORK ABILITY 11 0.0005
688 HAEMORRHAGIC STROKE 4 0.0005
689 COLD SWEAT 9 0.0005
690 MENTAL DISORDER 22 0.0005
691 DYSPNOEA EXERTIONAL 19 0.0005
692 BLOOD ALBUMIN DECREASED 4 0.0005
693 CARDIOMEGALY 6 0.0005
694 NAUSEA 384 0.0005
695 HYPERKALAEMIA 17 0.0005
696 SKELETAL INJURY 5 0.0005
697 HAEMODIALYSIS 4 0.0005
698 UPPER GASTROINTESTINAL HAEMORRHAGE 8 0.0005
699 HERPES ZOSTER 27 0.0005
700 HYPOTHYROIDISM 15 0.0005
701 BONE LOSS 7 0.0005
702 PAIN 284 0.0005
703 DYSURIA 17 0.0005
704 ANXIETY 128 0.0004
705 HAEMOLYTIC ANAEMIA 4 0.0004
706 ADVERSE EVENT 41 0.0004
707 WHITE BLOOD CELL COUNT INCREASED 17 0.0004
708 EXTRAPYRAMIDAL DISORDER 11 0.0004
709 MITRAL VALVE INCOMPETENCE 5 0.0004
710 LUPUS-LIKE SYNDROME 4 0.0004
711 HALLUCINATION, AUDITORY 7 0.0004
712 OPTIC NEURITIS 4 0.0004
713 ABSCESS 7 0.0004
714 ABDOMINAL PAIN 102 0.0004
715 RESPIRATORY DISTRESS 12 0.0004
716 BLOOD POTASSIUM INCREASED 7 0.0004
717 TACHYCARDIA 38 0.0004
718 LETHARGY 24 0.0004
719 TYPE 2 DIABETES MELLITUS 14 0.0004
720 WEIGHT DECREASED 116 0.0004
721 GASTROINTESTINAL DISORDER 37 0.0004
722 DIZZINESS POSTURAL 4 0.0004
723 METRORRHAGIA 7 0.0004
724 MELAENA 9 0.0004
725 MUSCLE SPASTICITY 5 0.0004
726 CARDIO-RESPIRATORY ARREST 17 0.0004
727 DELIRIUM 14 0.0004
728 DEPRESSION 90 0.0004
729 ABDOMINAL PAIN LOWER 10 0.0004
730 BONE MARROW FAILURE 8 0.0004
731 MOTOR DYSFUNCTION 4 0.0004
732 PULMONARY EMBOLISM 37 0.0004
733 GENERAL PHYSICAL HEALTH DETERIORATION 45 0.0004
734 MYALGIA 66 0.0004
735 GYNAECOMASTIA 12 0.0004
736 INFLAMMATION 20 0.0004
737 TOOTH LOSS 8 0.0004
738 DEEP VEIN THROMBOSIS 25 0.0004
739 ANGINA PECTORIS 11 0.0004
740 PETECHIAE 4 0.0004
741 FOLLICULITIS 4 0.0004
742 NEOPLASM PROGRESSION 13 0.0004
743 DIARRHOEA 239 0.0004
744 ALTERED STATE OF CONSCIOUSNESS 8 0.0004
745 HYPOXIA 13 0.0004
746 CEREBRAL INFARCTION 9 0.0004
747 BLINDNESS 15 0.0004
748 HEADACHE 230 0.0004
749 DECREASED APPETITE 85 0.0004
750 BLOOD CHOLESTEROL INCREASED 17 0.0004
751 EPILEPSY 11 0.0004
752 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
753 HYPOTENSION 72 0.0004
754 BLOOD UREA INCREASED 6 0.0004
755 BLOOD CALCIUM DECREASED 4 0.0004
756 SKIN REACTION 5 0.0004
757 DEPRESSED LEVEL OF CONSCIOUSNESS 14 0.0004
758 HEPATOCELLULAR INJURY 5 0.0004
759 SINUS TACHYCARDIA 5 0.0004
760 CARDIOGENIC SHOCK 5 0.0003
761 FATIGUE 271 0.0003
762 NEOPLASM 4 0.0003
763 DISEASE PROGRESSION 41 0.0003
764 DYSARTHRIA 13 0.0003
765 BODY TEMPERATURE INCREASED 7 0.0003
766 COLITIS 13 0.0003
767 DRUG ERUPTION 6 0.0003
768 OFF LABEL USE 296 0.0003
769 ISCHAEMIC STROKE 6 0.0003
770 MUSCLE RIGIDITY 4 0.0003
771 FEBRILE NEUTROPENIA 22 0.0003
772 LEUKOCYTOSIS 6 0.0003
773 BLOOD PRESSURE DECREASED 22 0.0003
774 LOWER RESPIRATORY TRACT INFECTION 15 0.0003
775 C-REACTIVE PROTEIN INCREASED 12 0.0003
776 NO THERAPEUTIC RESPONSE 4 0.0003
777 LIVER INJURY 8 0.0003
778 MENTAL STATUS CHANGES 9 0.0003
779 PRODUCT USE IN UNAPPROVED INDICATION 80 0.0003
780 ASTHENIA 120 0.0003
781 PRODUCT USE COMPLAINT 5 0.0003
782 GASTRIC ULCER 6 0.0003
783 SLEEP APNOEA SYNDROME 6 0.0003
784 RASH PRURITIC 17 0.0003
785 SENSORY DISTURBANCE 5 0.0003
786 GLAUCOMA 6 0.0003
787 HIP FRACTURE 10 0.0003
788 SKIN ULCER 8 0.0003
789 EYE DISORDER 10 0.0003
790 PERICARDIAL EFFUSION 7 0.0003
791 SPINAL FRACTURE 6 0.0003
792 CONVULSION 17 0.0003
793 FACE OEDEMA 5 0.0003
794 SCAR 5 0.0003
795 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 16 0.0003
796 PLATELET COUNT DECREASED 31 0.0003
797 HYPOGLYCAEMIA 14 0.0003
798 POLLAKIURIA 12 0.0003
799 CARDIAC FAILURE 23 0.0003
800 RASH MACULAR 10 0.0003
801 SEIZURE 33 0.0003
802 ABASIA 7 0.0003
803 AGGRESSION 14 0.0003
804 POOR QUALITY SLEEP 6 0.0003
805 GOUT 5 0.0003
806 HYPOKINESIA 4 0.0003
807 FLUID OVERLOAD 4 0.0003
808 COUGH 77 0.0003
809 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
810 BONE DISORDER 5 0.0003
811 DYSSTASIA 8 0.0003
812 ACCIDENTAL OVERDOSE 10 0.0003
813 ANGIOEDEMA 12 0.0003
814 VISUAL ACUITY REDUCED 9 0.0003
815 CONJUNCTIVITIS 5 0.0003
816 ABDOMINAL DISTENSION 28 0.0003
817 LUNG DISORDER 13 0.0003
818 CHEST PAIN 49 0.0003
819 HYPOCALCAEMIA 5 0.0003
820 MUSCULOSKELETAL DISORDER 5 0.0003
821 FEMUR FRACTURE 8 0.0003
822 DELUSION 4 0.0003
823 CHILLS 30 0.0003
824 SLEEP DISORDER 18 0.0003
825 ABNORMAL BEHAVIOUR 10 0.0003
826 HAEMOPTYSIS 7 0.0003
827 OXYGEN SATURATION DECREASED 14 0.0002
828 URINARY TRACT INFECTION 42 0.0002
829 SWELLING FACE 16 0.0002
830 PULMONARY OEDEMA 11 0.0002
831 RED BLOOD CELL COUNT DECREASED 7 0.0002
832 STAPHYLOCOCCAL INFECTION 8 0.0002
833 PERICARDITIS 4 0.0002
834 MOBILITY DECREASED 17 0.0002
835 CARDIOVASCULAR DISORDER 6 0.0002
836 EATING DISORDER 5 0.0002
837 LIVER FUNCTION TEST INCREASED 5 0.0002
838 IRRITABILITY 14 0.0002
839 MUSCULOSKELETAL DISCOMFORT 4 0.0002
840 ARRHYTHMIA 11 0.0002
841 OCULAR HYPERAEMIA 11 0.0002
842 THERAPEUTIC RESPONSE DECREASED 14 0.0002
843 DRUG INEFFECTIVE 304 0.0002
844 FAECES DISCOLOURED 5 0.0002
845 PRODUCTIVE COUGH 11 0.0002
846 CARDIAC ARREST 19 0.0002
847 MALAISE 100 0.0002
848 HEART RATE DECREASED 8 0.0002
849 DISORIENTATION 9 0.0002
850 DEPRESSED MOOD 12 0.0002
851 LOSS OF CONSCIOUSNESS 29 0.0002
852 DISTURBANCE IN ATTENTION 12 0.0002
853 CHROMATURIA 5 0.0002
854 OSTEOMYELITIS 4 0.0002
855 MOVEMENT DISORDER 7 0.0002
856 AGITATION 16 0.0002
857 NIGHT SWEATS 7 0.0002
858 CONFUSIONAL STATE 35 0.0002
859 FEELING COLD 6 0.0002
860 VERTIGO 13 0.0002
861 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
862 COMA 10 0.0002
863 MUSCULOSKELETAL PAIN 11 0.0002
864 INCREASED APPETITE 4 0.0002
865 LOWER LIMB FRACTURE 4 0.0002
866 DIABETIC KETOACIDOSIS 5 0.0002
867 SUICIDAL IDEATION 19 0.0002
868 PRESYNCOPE 5 0.0002
869 HAEMORRHOIDS 4 0.0002
870 ORAL HERPES 4 0.0002
871 HAEMATOCRIT DECREASED 4 0.0002
872 BLOOD POTASSIUM DECREASED 6 0.0002
873 GAIT DISTURBANCE 38 0.0002
874 DEATH 169 0.0002
875 CEREBRAL HAEMORRHAGE 7 0.0002
876 DEHYDRATION 26 0.0002
877 RIB FRACTURE 4 0.0002
878 HYPOAESTHESIA 29 0.0002
879 MUSCULAR WEAKNESS 22 0.0002
880 DYSPNOEA 108 0.0002
881 MOUTH ULCERATION 4 0.0002
882 OSTEOARTHRITIS 8 0.0002
883 EYE SWELLING 7 0.0002
884 FEAR 5 0.0002
885 INTERSTITIAL LUNG DISEASE 9 0.0002
886 VAGINAL HAEMORRHAGE 8 0.0002
887 MOOD ALTERED 5 0.0002
888 CEREBROVASCULAR ACCIDENT 31 0.0002
889 STOMATITIS 11 0.0002
890 SKIN DISORDER 6 0.0002
891 SKIN EXFOLIATION 15 0.0002
892 HOSPITALISATION 27 0.0002
893 GASTRIC DISORDER 6 0.0002
894 DYSPEPSIA 17 0.0002
895 RHINORRHOEA 11 0.0002
896 BRADYCARDIA 9 0.0002
897 SOMNOLENCE 34 0.0002
898 RESPIRATORY DISORDER 5 0.0002
899 INSOMNIA 44 0.0002
900 PLEURAL EFFUSION 10 0.0002
901 RECTAL HAEMORRHAGE 7 0.0002
902 HAEMORRHAGE 17 0.0002
903 HYPOPHAGIA 4 0.0002
904 BONE PAIN 9 0.0002
905 IMPAIRED HEALING 5 0.0002
906 TREMOR 25 0.0002
907 ABDOMINAL PAIN UPPER 31 0.0002
908 URINARY RETENTION 5 0.0001
909 GAIT INABILITY 5 0.0001
910 SUICIDE ATTEMPT 9 0.0001
911 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
912 WHITE BLOOD CELL COUNT DECREASED 16 0.0001
913 WEIGHT INCREASED 33 0.0001
914 RESPIRATORY ARREST 4 0.0001
915 DRUG ABUSE 12 0.0001
916 ARTHROPATHY 8 0.0001
917 BLISTER 8 0.0001
918 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
919 OROPHARYNGEAL PAIN 13 0.0001
920 SYNCOPE 14 0.0001
921 HYPOACUSIS 6 0.0001
922 PAIN IN EXTREMITY 40 0.0001
923 SPEECH DISORDER 7 0.0001
924 HALLUCINATION 10 0.0001
925 DIZZINESS 66 0.0001
926 GASTROINTESTINAL HAEMORRHAGE 11 0.0001
927 HEART RATE INCREASED 13 0.0001
928 DISCOMFORT 8 0.0001
929 TINNITUS 6 0.0001
930 FLUSHING 13 0.0001
931 PRURITUS 49 0.0001
932 HAEMATOCHEZIA 7 0.0001
933 MEDICATION ERROR 7 0.0001
934 NECK PAIN 7 0.0001
935 FUNGAL INFECTION 4 0.0001
936 PALPITATIONS 14 0.0001
937 CELLULITIS 6 0.0001
938 THERAPY CESSATION 6 0.0001
939 NERVOUSNESS 6 0.0001
940 ECZEMA 6 0.0001
941 PARAESTHESIA 18 0.0001
942 INTENTIONAL PRODUCT USE ISSUE 10 0.0001
943 MUSCULOSKELETAL STIFFNESS 10 0.0001
944 COMPLETED SUICIDE 9 0.0001
945 MALIGNANT NEOPLASM PROGRESSION 11 0.0001
946 INTESTINAL OBSTRUCTION 4 0.0001
947 ARTHRALGIA 44 0.0001
948 FLATULENCE 6 0.0001
949 PRODUCT SUBSTITUTION ISSUE 6 0.0001
950 BLOOD GLUCOSE INCREASED 19 0.0001
951 DYSKINESIA 4 0.0001
952 INFLUENZA LIKE ILLNESS 8 0.0001
953 FEELING ABNORMAL 23 0.0001
954 ABDOMINAL DISCOMFORT 16 0.0001
955 VISION BLURRED 13 0.0001
956 DYSGEUSIA 7 0.0001
957 NO ADVERSE EVENT 17 0.0001
958 INTENTIONAL OVERDOSE 6 0.0001
959 AMNESIA 6 0.0001
960 DRY SKIN 12 0.0001
961 MUSCLE SPASMS 16 0.0001
962 CARDIAC FAILURE CONGESTIVE 7 0.0001
963 ILL-DEFINED DISORDER 5 0.0001
964 BRONCHITIS 6 0.0001
965 EPISTAXIS 6 0.0001
966 MEMORY IMPAIRMENT 11 0.0001
967 DRUG EFFECT DECREASED 4 0.0001
968 INFLUENZA 8 0.0001
969 URTICARIA 12 0.0001
970 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
971 FALL 23 0.0001
972 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 12 0.0001
973 HOT FLUSH 5 0.0001
974 CARDIAC DISORDER 6 0.0001
975 SWELLING 6 0.0001
976 CHEST DISCOMFORT 6 0.0001
977 BURNING SENSATION 4 0.0001
978 COVID-19 10 0.0001
979 CONTUSION 5 0.0001
980 PERIPHERAL SWELLING 8 0.0001
981 NASOPHARYNGITIS 9 0.0000
982 ALOPECIA 9 0.0000
983 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9 0.0000
984 BREAST CANCER 4 0.0000
985 ATRIAL FIBRILLATION 4 0.0000
986 PRODUCT DOSE OMISSION ISSUE 12 0.0000
987 VISUAL IMPAIRMENT 5 0.0000
988 INCORRECT DOSE ADMINISTERED 9 0.0000
989 BLOOD PRESSURE INCREASED 6 0.0000
990 DRUG DOSE OMISSION 4 0.0000